In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis

Figure 3

Mean of percentage difference of total BMD in lumbar spine, distal femur, and proximal tibia between week 0 (baseline) and week 8. BMD changes at different regions with different treatment, were illustrated: (a) lumbar spine with alendronate; (b) lumbar spine with raloxifene; (c) distal femur with alendronate; (d) distal femur with raloxifene; (e) proximal tibia with alendronate; (f) proximal tibia with raloxifene. The error bar represents the SEM. Significant difference: *𝑃<0.05; **𝑃<0.01; ***𝑃<0.001 for difference from OVX group without treatment at the corresponding time point.

(a)

(b)

(c)

(d)

(e)

(f)